Navigation Links
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Date:11/18/2011

//www.regeneron.com/EYLEA-fpi.pdf">www.regeneron.com/EYLEA-fpi.pdf.

About the EYLEA™ (aflibercept) Injection Global CollaborationRegeneron is collaborating with Bayer HealthCare on the global development of EYLEA.  Bayer submitted an application for marketing authorization in Europe for wet AMD in June 2011.

Bayer HealthCare will market EYLEA outside the United States, where the companies will share equally the profits from any future sales of EYLEA.  Regeneron maintains exclusive rights to EYLEA in the United States.

About Wet AMDAge-related macular degeneration (AMD) is a leading cause of acquired blindness.  Macular degeneration is diagnosed as either dry (non-exudative) or wet (exudative).  In wet AMD, new blood vessels grow beneath the retina and leak blood and fluid.  This leakage causes disruption and dysfunction of the retina creating distortion and/or blind spots in central vision.  Wet AMD is the leading cause of blindness for people over the age of 65 in the U.S. and Europe.

Conference Call InformationLeonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, and other members of senior management will host a conference call to discuss the FDA approval of EYLEA for the treatment of patients with wet AMD and launch plans, as well as other corporate matters.  The interactive call will be held on November 18, 2011 at 6:30 p.m. Eastern Time and can be accessed live through the Regeneron website at www.regeneron.com on the Investor Relations page.  The call, including the question and answer session, can also be accessed by dialing:

Domestic Dial-in Number:  (888) 660-6127
International Dial-in Number:  (973) 890-8355
Participant Passcode:  30193445

An archived version of the conference call will be available for 30 days on the company's website at

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
2. Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
3. Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
4. Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting
5. Regeneron Reports Second Quarter 2011 Financial and Operating Results
6. Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
7. Trading in Regeneron Common Stock Halted
8. Regeneron Reports First Quarter 2011 Financial and Operating Results
9. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
10. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
11. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... N.J. , May 23, 2013 Nephros, ... commercial stage medical device company that develops and sells ... completion of its rights offering.  In addition, the concurrent ... 2011 warrants expired on May 17, 2013. ... $3.0 million from the rights offering.   A portion of ...
(Date:5/23/2013)... , May 23, 2013  A recently published clinical ... Houston, Texas , demonstrates that 3D mammography ... cancer detection. The study, "Implementation of ... Study," was led by Stephen L. Rose ... of the American Journal of Roentgenology (AJR). ...
(Date:5/23/2013)... IRVINE, Calif. , May 23, 2013 ... breast cancer may not benefit from chemotherapy and still ... announced the launch of one of the largest sources ... The new website and interactive Facebook page provide recently ... if they can safely avoid chemotherapy. "We ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... Calif., May 16, 2011 diaDexus, Inc. (OTC Bulletin Board: ... development and commercialization of patent-protected in vitro diagnostic ... results for the first quarter of 2011. Total ... million, representing 25% growth over total revenues of $2.7 million ...
... On April 28, 2011 the New England Journal ... ongoing "Comparisons of Age-Related Macular Degeneration Treatments Trials" (CATT). ... primary market research and influence network mapping, has conducted ... to gauge their reactions on the heels of this ...
Cached Medicine Technology:diaDexus, Inc. Reports 2011 First Quarter Financial Results 2diaDexus, Inc. Reports 2011 First Quarter Financial Results 3diaDexus, Inc. Reports 2011 First Quarter Financial Results 4diaDexus, Inc. Reports 2011 First Quarter Financial Results 5AlphaDetail AlphaPulse™: Anticipated Impact of CATT Trial in Wet AMD Treatment 2
(Date:5/25/2013)... May 25, 2013 Dr. Leslie Gerstman ... procedure FDA-approved to lift skin on the neck, on the ... her practice, Medical Aesthetics. , Ultherapy is a non-surgical procedure ... natural healing process to lift the skin over time. The ... time, to see and then treat the deepest support layers ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Communities of ... Texas. It is the fifth largest media market in the ... the number one visitor destination in Texas and a major ... to the American West as it is home to many ... will enjoy from sports to the arts. Residents and locals ...
(Date:5/25/2013)... -- Many viruses and parasites that affect both dogs ... bacteria-borne illness than can result in liver or kidney ... to a veterinarian. These germs could be ... said Dr. Susan Nelson, a clinical associate professor at ... serious diseases can be fatal, even with treatment," she ...
(Date:5/25/2013)... May 25, 2013 Radius Engineering ... shelter company in the US and has been ... for over 35 years. M.E. and President, Walton ... of NBC Weapon Fundamentals and Shelter Engineering Standards, ... bible on shelter engineering. McCarthy is considered the ...
(Date:5/25/2013)... Absolute Surgical Specialists, serving Sun City Center for ... throughout the country participating in Shop Local for a Cause. ... event as he understands what military families go through after ... said, “I wanted to give something back, as I not ... here too.” , Shop Local for a Cause has chosen ...
Breaking Medicine News(10 mins):Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2
... ... series of free 90-minute online classes this month to help returning combat veterans and ... critical for combat veterans and families. , ... (PRWEB) November 12, 2009 -- The nonprofit PAIRS Foundation will ...
... Catholic ... , ... (PRWEB) November 11, 2009 -- Drexel University Online honored Catholic Health East ... to training and development through various forms of eLearning to meet business goals and ...
... ... and design services, Ms. McKenna and the Beyond the Box team can assist seniors and ... , ... -- The Washington, DC based relocation and design firm, Beyond the Box , is ...
... ... core lab market with largest number of highly automated QT(sm) studies. , ... Rochester, NY (PRWEB) November 11, ... and QT analysis, announced today that a top five pharmaceutical company has awarded iCardiac ...
... High levels of workplace exposure to Bisphenol-A may increase the ... Kaiser Permanente study appearing online in the journal Human ... The five-year study examined 634 workers in factories in China, ... of workers in factories where no BPA was present. The ...
... Public Health researchers will present Nov. 11 on a ... annual meeting in Philadelphia, including a study that found ... wellness program. Additional public health research findings ... faith affect how Southern African-American women use contraception? , ...
Cached Medicine News:Health News:PAIRS Foundation Offering Free Classes to Help Combat Veterans Impacted by PTSD 2Health News:PAIRS Foundation Offering Free Classes to Help Combat Veterans Impacted by PTSD 3Health News:Catholic Health East Named 2009 National Distance Learning Week Award Recipient 2Health News:Catholic Health East Named 2009 National Distance Learning Week Award Recipient 3Health News:Relocation Specialists Beyond the Box Team With Nurse to Help Facilitate Senior Moves 2Health News:Relocation Specialists Beyond the Box Team With Nurse to Help Facilitate Senior Moves 3Health News:Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 2Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 2Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 3Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 4Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 5Health News:Worksite wellness programs may reduce employee absenteeism 2
The Perkins has been established for well over 20 years as a "world standard" for hand held applanation tonometers....
... Topcon, leader in ... offers the most advanced ... operational conveniences and totally ... Auto Refractometry and Auto ...
... examination time and ease of use makes working ... The advanced touch-screen display allows you to perform ... movement. Capture one eye on the display ... With the new features, the RC-5000 will ...
... The Worlds First Combination Unit, the M3,Marco ... Keratometer, and Non-Contact Tonometer. By combining automatic ... you to save time while providing the ... from Marco. The M3 not only saves ...
Medicine Products: